GLP-3 Reta | Cagrilintide | 5/5mg

GLP-3 Reta / Cagrilintide 5mg / 5mg is a synthetic peptide blend combining Retatrutide, a triple receptor agonist studied for activity at GLP-1, GIP, and glucagon receptors, with Cagrilintide, a long-acting amylin analog. The combination is commonly of interest in laboratory research examining complementary metabolic, endocrine, and satiety-signaling pathways. The specific Retatrutide + Cagrilintide combination has not been established as a standardized formulation or evaluated in published controlled human trials.

Specifications

Composition: Retatrutide 5mg + Cagrilintide 5mg
GLP-3 Reta CAS: 2381089-83-2
GLP-3 Reta Molecular Formula: C221H342N46O68
GLP-3 Reta Molecular Weight: 4731.35 g/mol
Cagrilintide Molecular Formula: C194H312N54O59S2
Cagrilintide Molecular Weight: 4051.1 g/mol
Type: Triple receptor agonist (GLP-1 / GIP / Glucagon) + long-acting amylin analog
Form: White lyophilized powder
Purity: ≥99%
Storage: 2–8°C

Research Applications

• Studied in research involving complementary incretin and amylin signaling pathways
• Investigated in laboratory models involving metabolic and endocrine signaling
• Of interest for research examining GLP-1, GIP, glucagon, and amylin receptor pathways
• Utilized in peptide-based metabolic signaling research